Navigation Links
Receptors involved in corneal clarity identified

The researchers at the Aberdeen University have found out molecules that could aid in the treatment of cancer, heart diseases and other serious disorders//.

The expression of this molecule, sflt-1, a free-floating receptor for vascular endothelial growth factor A, prevents the formation of vision obstructing blood vessels, thus keeps the cornea clear.

According to the researchers, this discovery could help in the development of new drugs, new therapies for eye diseases and eye injuries. The Aberdeen team and colleagues at the Medical College of Georgia and the University of Kentucky in the US conducted this research.

Dr Martin Collinson, senior lecturer at the University of Aberdeen, said, "The molecule is an amazing finding". He added: "The cornea is widely used by scientists who hope to study how blood vessels grow or how to inhibit the growth of new blood vessels. "This knowledge will help to treat diseases like cancer, heart disease, rheumatoid arthritis, stroke and eye disorders like macular degeneration. "The cornea is our window on the world. If it contained blood vessels it would not be transparent and we would not be able to see. "If you study a normal eye you will see blood vessels in the whites of the eye but these stop at the cornea."

The cornea could get vascularised or form blood vessels due to disease or injury. Tumors are able to grow due to their capacity to attract blood vessels. Hence, vascularisation is crucial in diseases like cancer.
GYT
'"/>




Page: 1

Related medicine news :

1. Effects Of Certain Food Related To Single Pain Receptors
2. Inhibitor That Blocks Host Receptors Found To be Effective In Treating Anthrax
3. Max Planck Researchers Incorporate Odorant Receptors into Artificial Membranes
4. Nitric oxide involved in high blood pressure
5. Scientists locate key hormone involved in appetite control
6. Risks involved in Procedural Sedation
7. Toxin causing Gastrointestinal problems identified
8. Gene Variant associated with Schizophrenia identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... ... Prater Eye Center becomes the first in the area to offer AngioPlex™ Optical ... signs of retinal disease, such as macular degeneration, diabetic retinopathy, and other vascular ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... Many individuals ... of protein for a multitude of reasons. IsoPasta by Isolator Fitness has delved ... it once more, but without the high-carb repercussions. IsoPasta has 30 grams of ...
(Date:2/13/2016)... ... February 13, 2016 , ... Christie Medical Holdings, ... gift of a VeinViewer® Vision vein finder for the nursing school ... an IV and draw blood, combining technology with traditional technique. , “VeinViewer is ...
(Date:2/12/2016)... CA (PRWEB) , ... February 12, 2016 , ... According ... hernia surgeries are beginning to account for a significant portion of hernia repairs throughout ... Towfigh of the Beverly Hills Hernia Center notes that this trend has not only ...
(Date:2/12/2016)... FL (PRWEB) , ... February 12, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – hosted over 250 members of South Florida’s philanthropic community at its 10th ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)...  Sequent Medical, Inc. announced today that it has ... safety and effectiveness of the WEB™ Aneurysm Embolization System ... Prof Laurent Spelle , MD, Head of Neuroradiology ... and Principal Investigator of the CLARYS study, ... and Germany.  Although patients with ruptured aneurysms have ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
(Date:2/12/2016)... WILMINGTON, North Carolina , 12 februari ... Laboratories, Inc. (AAI/CML), een toonaangevende leverancier van ... farmaceutische en biotechnologische industrieën, kondigt vandaag een ... en mogelijkheden op haar locatie in ... in vraag heeft geleid tot meerdere recente ...
Breaking Medicine Technology: